ROCKVILLE Md. April 1 2015 PRNewswire Synthetic Biologics Inc. NYSE MKT SYN a developer of pathogenspecific therapies for serious infections and diseases with a focus on protecting the microbiome today announced that clinical data supporting the developme...
↧